Line 363: | Line 363: | ||
<li><a href="https://2016.igem.org/Team:CGU_Taiwan/Parts">PARTS</a></li> | <li><a href="https://2016.igem.org/Team:CGU_Taiwan/Parts">PARTS</a></li> | ||
</ul> | </ul> | ||
+ | /* | ||
<div class="circle"><img style="position:absolute;z-index:+1;width:90%;height:95%;margin-left:3%;margin-top:2%;" src="https://static.igem.org/mediawiki/2016/8/8a/CGU_Taiwan--logo9.jpg"></div> | <div class="circle"><img style="position:absolute;z-index:+1;width:90%;height:95%;margin-left:3%;margin-top:2%;" src="https://static.igem.org/mediawiki/2016/8/8a/CGU_Taiwan--logo9.jpg"></div> | ||
+ | */ | ||
</header> | </header> | ||
Revision as of 03:40, 27 November 2016
Achievement
- We had a great summer, and attend the Giant Jamboree
- Meet all deliverables on the Requirements page
- Create a page on wiki with clear attribution.
- Part / Contribution- BBa_K1955003 and BBa_K1955004 which represent our contribution for the bronze medal.
- BBa_K1955000 is an hemagglutinin for further immunology study.
- Our collaborations are listed here.
- We participated many activities such as education, public perception, and survey.
- We present multiple issues of our product after carrying out the survey and communication for our integrated human practices.
- The proof of concept shows that our project results and value of our product.
- We demonstrate our project with our prediction platform which could apply in a real world.